VDR Gene variation and insulin resistance related diseases

Fei-fei Han,Ya-li Lv,Li-li Gong,He Liu,Zi-rui Wan,Li-hong Liu
DOI: https://doi.org/10.1186/s12944-017-0477-7
2017-08-19
Lipids in Health and Disease
Abstract:BackgroundVitamin D status may influence the risk of Insulin resistance related diseases such as Type 2 diabetes (T2DM), metabolic syndrome (MetS), and polycystic ovarian syndrome (PCOS). Several studies have assessed vitamin D receptor (VDR) gene polymorphism in relationship with these diseases; however, results remain inconsistent. Our study was conducted to elucidate whether VDR Gene polymorphisms could predict insulin resistance on a large scale.MethodsA meta-analysis using MEDLINE and EMBASE, was performed up to December 16th, 2016. Studies reporting association of vitamin D gene polymorphism with incident T2DM, MetS and PCOS outcomes were included and sub-group analysis by pigment of skin and latitude were performed.ResultsA total of 28 articles based on four gene variation, and comprising 9232 participants with 5193 Insulin resistance related diseases patients were included. No significant associations of the VDR ApaI, BsmI, FokI and TaqI variant with Insulin resistance related diseases were found. However, sub-group analysis analysis showed that PCOS in TaqI (OR = 1.47, 95% CI = 1.03–2.09, P = 0.03) for T allele and MetS for G allele (OR = 1.41, 95% CI = 1.07–1.85, P = 0.01) in BsmI was significant association with VDR gene polymorphism. Simultaneously, sub-group analysis showed VDR ApaI rs7975232(G > T)variant was associated with insulin resistance related diseases in Asians (GG/GT + TT) (OR, 1.62; 95% CI, 1.03–2.53; P = 0.04) and population who lived in middle latitude district (30–60°) (GG/GT + TT) (OR, 1.22; 95% CI, 1.04–1.43; P = 0.02), VDR BsmI rs1544410 (A > G)and VDR Taq1rs731236 (T/C) variant were associated with insulin resistance related diseases in Caucasian (dark-pigmented).ConclusionThe results suggested that the association between insulin resistance related diseases and VDR ApaI, BsmI, FokI variant was more obvious in dark-pigmented Caucasians and Asians but not in Caucasian with white skin.
biochemistry & molecular biology,nutrition & dietetics
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore whether vitamin D receptor (VDR) gene polymorphisms can predict the risk of insulin - resistance - related diseases. Specifically, through meta - analysis, the researchers evaluated the associations between four variants of the VDR gene (ApaI, BsmI, FokI, and TaqI) and type 2 diabetes mellitus (T2DM), metabolic syndrome (MetS), and polycystic ovary syndrome (PCOS). The main purpose of the study was to determine whether these gene variants have predictive value for the occurrence of insulin - resistance - related diseases in different populations (such as populations with different skin colors and latitudes of residence). The study found that in the overall analysis, there were no significant associations between the ApaI, BsmI, and FokI variants of the VDR gene and insulin - resistance - related diseases. However, in the subgroup analysis, the study found: - For the TaqI variant, its T allele was significantly associated with PCOS (odds ratio [OR] = 1.47, 95% confidence interval [CI] = 1.03 – 2.09, P = 0.03). - For the BsmI variant, its G allele was significantly associated with MetS (OR = 1.41, 95% CI = 1.07 – 1.85, P = 0.01). At the same time, the subgroup analysis also showed that the VDR ApaI rs7975232(G > T) variant was significantly associated with insulin - resistance - related diseases in Asian populations (GG/GT + TT) (OR, 1.62; 95% CI, 1.03 – 2.53; P = 0.04) and in populations living in mid - latitude areas (30 – 60°) (GG/GT + TT) (OR, 1.22; 95% CI, 1.04 – 1.43; P = 0.02). In addition, the VDR BsmI rs1544410 (A > G) and VDR Taq1rs731236 (T/C) variants were also significantly associated with insulin - resistance - related diseases in dark - skinned Caucasians. In conclusion, this study aims to clarify the distribution of VDR gene polymorphisms in different populations and their relationships with the risk of insulin - resistance - related diseases, in order to provide new perspectives for the prevention and treatment of these diseases.